BioDelivery Sciences International
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioDelivery Sciences International's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7% to $166,703,000. The net income raised on $84,860,000 and profit margin reached 51%. Total operating expenses were $106,206,000.

Profit Margin

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Profit margin
2012 54.54M 1.65M 3.03%
2013 11.35M -57.39M -505.41%
2014 38.94M -54.21M -139.22%
2015 48.23M -37.67M -78.11%
2016 15.54M -67.13M -431.87%
2017 61.98M 5.28M 8.53%
2018 55.64M -33.86M -60.87%
2019 111.38M -15.30M -13.74%
2020 156.47M 25.71M 16.43%
2021 166.70M 84.86M 50.9%

BDSI Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
166.70M156.47M111.38M55.64M61.98M15.54M48.23M38.94M11.35M54.54M
Cost of revenue
23.37M24.66M21.59M15.78M19.49M11.25M8.10M4.93M2.08M1.90M
Gross profit
143.33M131.80M89.79M39.85M42.48M4.28M40.13M34.00M9.27M52.63M
Operating exp.
Research and development
0004.90M13.04M18.87M20.62M34.28M53.32M35.36M
Selling and marketing
0000000000
Total operating expenses
106.20M98.82M86.06M63.50M71.90M68.22M75.30M72.74M65.67M45.57M
Operating income
37.12M32.97M3.73M-23.64M-29.42M-63.93M-35.17M-38.74M-56.40M7.06M
Other income (expenses), net
-7.50M-7.01M-19.03M-14K18.73M64K-2.49M-15.47M-991.67K-5.28M
Income before tax
29.62M25.96M-15.3M-33.85M-10.68M-67.13M-37.67M-54.21M-57.39M1.78M
Income tax expense
-55.23M252K5K13K-15.97M64K25K-13.46M-89.01K129.12K
Net income
84.86M25.71M-15.30M-33.86M5.28M-67.13M-37.67M-54.21M-57.39M1.65M
Earnings per share
Basic EPS
0.850.26-0.18-0.540.1-1.25-0.72-1.12-1.510.05
Diluted EPS
0.820.24-0.18-0.540.09-1.25-0.72-1.12-1.510.05
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source